Purple Footprints
How the immune system influences pancreatic cancer
Groundbreaking research from the University Medical Center Göttingen (UMG) in Germany, recently published in the prestigious journal Nature Communications, has shed new light on how pancreatic cancer interacts with the immune system opening the door to innovative new therapies that could change the future for those diagnosed.
Read story ➞
How Dr Andrew Lowy’s global expertise keeps the focus where it’s needed most
Dr Andrew Lowy, Chief of Surgical Oncology at Moores Cancer Center, University of California, San Diego, is an internationally renowned surgeon and scientist. As a member of Pankind’s Scientific Advisory Panel, he plays a key role in shaping our research strategy and has shared some of his key findings at our annual Scientific Meetings.
Read story ➞
A new national framework progressing access to genomics - Amber Johns, Head of Programs & Research
The Australian cancer care landscape is evolving, and we welcome the recent release of Cancer Australia’s National Framework for Genomics in Cancer Control.
Read story ➞
2024 Year in Numbers
Together with our donors, fundraisers, partners, supporters, volunteers and global allies we’re making real strides in the fight for better outcomes for people affected by pancreatic cancer. Our achievements, milestones and progress are a testament to the unwavering dedication of our community.
Read story ➞